PRKAA2 and Alzheimer disease: Also tacrine, an acethylcholinesterase inhibitor widely used for the treatment of AD, was shown to induce up-regulation of AMPK subunits in an in vitro model (E-MTAB-798 in expression ATLAS http://www.ebi.ac.uk/gxa/) [43].